Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 28
Filtrar
2.
Virchows Arch ; 474(1): 117-123, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30194489

RESUMO

Primary classic Hodgkin lymphoma of the gastrointestinal tract represents a rare occurrence. A full patient's work-up is essential in order to exclude a secondary intestinal involvement. Histologically Epstein-Barr virus mucocutaneous ulcer closely resembles Hodgkin lymphoma. The differential diagnosis between these two entities is relevant, since both the therapeutic approach and the clinical behavior are different. Herein, we describe a case of primary classic Hodgkin lymphoma arising in the ileum and a case of Epstein-Barr virus mucocutaneous ulcer of the colon, focusing on the main clinicopathological differences.


Assuntos
Doenças do Colo/patologia , Infecções por Vírus Epstein-Barr/patologia , Doença de Hodgkin/patologia , Neoplasias do Íleo/patologia , Infecções Oportunistas/patologia , Úlcera/patologia , Adulto , Idoso de 80 Anos ou mais , Biomarcadores Tumorais/análise , Biópsia , Doenças do Colo/imunologia , Doenças do Colo/virologia , Diagnóstico Diferencial , Infecções por Vírus Epstein-Barr/imunologia , Infecções por Vírus Epstein-Barr/virologia , Feminino , Doença de Hodgkin/tratamento farmacológico , Doença de Hodgkin/metabolismo , Humanos , Neoplasias do Íleo/química , Neoplasias do Íleo/tratamento farmacológico , Hospedeiro Imunocomprometido , Imuno-Histoquímica , Imunossupressores/efeitos adversos , Masculino , Metotrexato/efeitos adversos , Infecções Oportunistas/imunologia , Infecções Oportunistas/virologia , Valor Preditivo dos Testes , Úlcera/imunologia , Úlcera/virologia
5.
Mol Pharm ; 14(8): 2660-2669, 2017 08 07.
Artigo em Inglês | MEDLINE | ID: mdl-28648081

RESUMO

The aim of the study was to use in silico and in vitro techniques to evaluate whether a triple formulation of antiretroviral drugs (tenofovir, darunavir, and dapivirine) interacted with P-glycoprotein (P-gp) or exhibited any other permeability-altering drug-drug interactions in the colorectal mucosa. Potential drug interactions with P-gp were screened initially using molecular docking, followed by molecular dynamics simulations to analyze the identified drug-transporter interaction more mechanistically. The transport of tenofovir, darunavir, and dapivirine was investigated in the Caco-2 cell models and colorectal tissue, and their apparent permeability coefficient (Papp), efflux ratio (ER), and the effect of transporter inhibitors were evaluated. In silico, dapivirine and darunavir showed strong affinity for P-gp with similar free energy of binding; dapivirine exhibiting a ΔGPB value -38.24 kcal/mol, darunavir a ΔGPB value -36.84 kcal/mol. The rank order of permeability of the compounds in vitro was tenofovir < darunavir < dapivirine. The Papp for tenofovir in Caco-2 cell monolayers was 0.10 ± 0.02 × 10-6 cm/s, ER = 1. For dapivirine, Papp was 32.2 ± 3.7 × 10-6 cm/s, but the ER = 1.3 was lower than anticipated based on the in silico findings. Neither tenofovir nor dapivirine transport was influenced by P-gp inhibitors. The absorptive permeability of darunavir (Papp = 6.4 ± 0.9 × 10-6 cm/s) was concentration dependent with ER = 6.3, which was reduced by verapamil to 1.2. Administration of the drugs in combination did not alter their permeability compared to administration as single agents. In conclusion, in silico modeling, cell culture, and tissue-based assays showed that tenofovir does not interact with P-gp and is poorly permeable, consistent with a paracellular transport mechanism. In silico modeling predicted that darunavir and dapivirine were P-gp substrates, but only darunavir showed P-gp-dependent permeability in the biological models, illustrating that in silico modeling requires experimental validation. When administered in combination, the disposition of the proposed triple-therapy antiretroviral drugs in the colorectal mucosa will depend on their distinctly different permeability, but was not interdependent.


Assuntos
Membro 1 da Subfamília B de Cassetes de Ligação de ATP/química , Darunavir/química , Pirimidinas/química , Tenofovir/química , Fármacos Anti-HIV/química , Fármacos Anti-HIV/uso terapêutico , Células CACO-2 , Doenças do Colo/prevenção & controle , Doenças do Colo/virologia , Darunavir/uso terapêutico , Infecções por HIV/prevenção & controle , Humanos , Simulação de Acoplamento Molecular , Pirimidinas/uso terapêutico , Tenofovir/uso terapêutico
7.
Saudi J Kidney Dis Transpl ; 25(3): 621-4, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-24821162

RESUMO

Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD) is a serious complication of organ transplantation. The gastrointestinal (GI) tract is a common site involved, but non-specific signs and symptoms often delay the diagnosis. We report a case of EBV-associated GI-PTLD in a 68-year-old kidney transplant patient who received the kidney ten months earlier. He presented with chronic diarrhea and developed massive pneumo-peritoneum secondary to multiple colonic perforations.


Assuntos
Doenças do Colo/etiologia , Infecções por Vírus Epstein-Barr/etiologia , Transplante de Rim/efeitos adversos , Transtornos Linfoproliferativos/etiologia , Idoso , Biópsia , Doença Crônica , Colectomia , Doenças do Colo/diagnóstico , Doenças do Colo/cirurgia , Doenças do Colo/virologia , Diarreia/etiologia , Infecções por Vírus Epstein-Barr/diagnóstico , Infecções por Vírus Epstein-Barr/virologia , Evolução Fatal , Humanos , Perfuração Intestinal/etiologia , Transtornos Linfoproliferativos/diagnóstico , Transtornos Linfoproliferativos/cirurgia , Transtornos Linfoproliferativos/virologia , Masculino , Pneumoperitônio/etiologia , Fatores de Risco , Fatores de Tempo , Resultado do Tratamento
9.
Lupus ; 21(4): 449-51, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22020267

RESUMO

We present the case of a 58-year-old woman with a long-standing history of systemic lupus erythematosus (SLE) who developed a cytomegalovirus (CMV) infection with colonic perforation and subsequent purulent peritonitis whilst using combined immunosuppressive therapy. The pathogenesis and the clinical presentation of this unique case is discussed in detail. Opportunistic infection should always be kept in mind in SLE patients presenting with fever. Viral serology should be routinely performed in these patients, especially when immunosuppressive therapy is given, to avoid delay in instituting adequate management and therapy.


Assuntos
Doenças do Colo/virologia , Infecções por Citomegalovirus/induzido quimicamente , Infecções por Citomegalovirus/virologia , Imunossupressores/efeitos adversos , Perfuração Intestinal/virologia , Lúpus Eritematoso Sistêmico/tratamento farmacológico , Infecções Oportunistas/induzido quimicamente , Infecções Oportunistas/virologia , Antivirais/uso terapêutico , Colectomia , Doenças do Colo/diagnóstico , Doenças do Colo/terapia , Colostomia , Infecções por Citomegalovirus/diagnóstico , Infecções por Citomegalovirus/terapia , Feminino , Humanos , Perfuração Intestinal/diagnóstico , Perfuração Intestinal/terapia , Pessoa de Meia-Idade , Infecções Oportunistas/diagnóstico , Infecções Oportunistas/terapia , Peritonite/induzido quimicamente , Peritonite/virologia , Resultado do Tratamento
16.
J Infect ; 54(1): e37-9, 2007 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16690133

RESUMO

A 27-week-old infant developed symptoms of bowel obstruction when full enteral feeds were started. Laparotomy revealed strictures in the ascending and proximal transverse colon. Right hemicolectomy was performed. Histological examination of the resected large bowel demonstrated the presence of Cytomegalovirus inclusion bodies. Cytomegalovirus infections of the gut are extremely rare in neonates. This case report alerts neonatologists and microbiologists to consider Cytomegalovirus infection as a possible cause of bowel obstruction and necrotising enterocolitis like symptoms.


Assuntos
Doenças do Colo/virologia , Infecções por Citomegalovirus/complicações , Citomegalovirus/isolamento & purificação , Doenças do Prematuro/virologia , Obstrução Intestinal/virologia , Colo Ascendente , Colo Transverso , Doenças do Colo/patologia , Infecções por Citomegalovirus/virologia , Feminino , Histocitoquímica , Humanos , Corpos de Inclusão Viral , Recém-Nascido , Doenças do Prematuro/patologia , Obstrução Intestinal/patologia , Laparotomia , Reino Unido
17.
J Infect Dis ; 189(8): 1382-7, 2004 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-15073674

RESUMO

BACKGROUND: Several studies have shown an association between vaccination with the rotavirus vaccine and the development of intussusception. We evaluated the plausibility of a causal association between natural rotavirus infection and intussusception. METHODS: We performed ultrasound measurements, in infants with confirmed rotavirus infection and in healthy control subjects, of the ileum wall thickness and mesenteric lymph nodes, at enrollment and 1 month later. RESULTS: Thirteen pairs of patients with rotavirus infection and control subjects were enrolled. The mean distal ileum wall thickness at the first examination was 3.0 mm in patients with rotavirus infection and 2.0 mm in control subjects (P = .037). The maximum lymph node size in patients with rotavirus infection was 11.6 mm at the first examination and 7.4 mm at the second examination (P = .017). Nodal aggregates and free fluid were also observed more commonly among patients with rotavirus infection (54% vs. 9%; P = .033 for both). CONCLUSION: Rotavirus infection was associated with increased distal ileum wall thickness and lymphadenopathy during the illness period. These changes suggest a plausible mechanism by which rotavirus infection could cause intussusception.


Assuntos
Doenças do Colo/virologia , Doenças do Íleo/virologia , Íleo/patologia , Intussuscepção/virologia , Infecções por Rotavirus/patologia , Rotavirus/crescimento & desenvolvimento , Estudos de Casos e Controles , Estudos de Coortes , Doenças do Colo/diagnóstico por imagem , Doenças do Colo/patologia , Feminino , Humanos , Doenças do Íleo/diagnóstico por imagem , Doenças do Íleo/patologia , Íleo/diagnóstico por imagem , Íleo/virologia , Lactente , Recém-Nascido , Intussuscepção/diagnóstico por imagem , Intussuscepção/patologia , Linfonodos/diagnóstico por imagem , Linfonodos/patologia , Linfonodos/virologia , Masculino , Projetos Piloto , Estudos Prospectivos , Infecções por Rotavirus/diagnóstico por imagem , Infecções por Rotavirus/virologia , Vacinas contra Rotavirus/efeitos adversos , Ultrassonografia
19.
Transpl Infect Dis ; 5(3): 147-50, 2003 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-14617304

RESUMO

Intestinal disorders are classical complications of cytomegalovirus (CMV) infection in kidney transplant recipients (Helderman JH, Goral S. Gastrointestinal complications of transplant immunosuppression. J Am Soc Nephrol 2002: 13: 277-287). Severe ulcerative colitis that is sometimes lethal has been reported (Foucar E, Mukai K, Foucar K, Sutherland DE, Van Buren CT. Colon ulceration in lethal cytomegalovirus infection. Am J Clin Pathol 1981: 76: 788-801 and Frankel AH, Barker F, Williams G, Benjamin IS, Lechler R, Rees AJ. Neutropenic enterocolitis in a renal transplant patient. Transplantation 1991: 52: 913-914). The immunosuppressive drugs currently used, and notably mycophenolate mofetil (Cellcept), cause significant changes in the incidence, duration, and viral load of CMV infections with severe atypical forms of CMV disease (De Maar EF, Verschuuren EA, Homan vd Heide JJ, et al. Effects of changing immunosuppressive regimen on the incidence, duration and viral load of cytomegalovirus infection in renal transplantation: a single center report. Transpl Infect Dis 2002: 4: 17-24 and Perez Valentin MA, Cofan F, Sole M, et al. Atypical cytomegalovirus in renal transplantation: a new form of presentation. Nefrologia 2002: 22: 381-385). This report describes a patient who suffered from several episodes of colitis due to an unusual and late-appearing CMV infection.


Assuntos
Colite/virologia , Doenças do Colo/virologia , Fístula Cutânea/virologia , Infecções por Citomegalovirus/virologia , Fístula Intestinal/virologia , Transplante de Rim/efeitos adversos , Antígenos Virais/análise , Colo/virologia , Citomegalovirus/imunologia , Citomegalovirus/isolamento & purificação , Feminino , Humanos , Pessoa de Meia-Idade , Recidiva
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA